{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:07:53Z","timestamp":1770883673815,"version":"3.50.1"},"reference-count":187,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.ahj.2005.03.007","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T13:46:10Z","timestamp":1141220770000},"page":"604-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacological and surgical treatments for obesity"],"prefix":"10.1016","volume":"151","author":[{"given":"Tracy","family":"DeWald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalita","family":"Khaodhiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark P.","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2005.03.007_bib1","series-title":"Contemporary diagnosis and management of obesity","first-page":"68","article-title":"Health hazards associated with overweight","author":"Bray","year":"1998"},{"key":"10.1016\/j.ahj.2005.03.007_bib2","series-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report","author":"United States Department of Health and Human Services","year":"1998"},{"key":"10.1016\/j.ahj.2005.03.007_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00006","article-title":"Medical hazards of obesity","volume":"119","author":"Pi-Sunyer","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archinte.159.8.837","article-title":"Impairment of health and quality of life using new US federal guidelines for the identification of obesity","volume":"159","author":"Lean","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib5","doi-asserted-by":"crossref","first-page":"508S","DOI":"10.1093\/ajcn\/55.2.508s","article-title":"Morbidity of severely obese patients","volume":"55","author":"Sjostrom","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ahj.2005.03.007_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00001574-199603000-00016","article-title":"Obesity and its health risks","volume":"12","author":"Halsted","year":"1996","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.ahj.2005.03.007_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/j.1550-8528.1998.tb00322.x","article-title":"Current estimates of the economic cost of obesity in the United States","volume":"6","author":"Wolf","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.ahj.2005.03.007_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/35007508","article-title":"Obesity as a medical problem","volume":"404","author":"Kopelman","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2005.03.007_bib9","series-title":"Handbook of obesity","first-page":"875","article-title":"Dietary treatment of obesity","author":"Van Gaal","year":"1998"},{"key":"10.1016\/j.ahj.2005.03.007_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/00003495-199243050-00007","article-title":"Dexfenfluramine: a review of its pharmacological properties and therapeutic potential in obesity","volume":"43","author":"McTavish","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.ahj.2005.03.007_bib11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/clpt.1992.68","article-title":"Long-term weight control: the National Heart, Lung, and Blood Institute Funded Multimodal Intervention Study","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2005.03.007_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.1992.69","article-title":"Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2005.03.007_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/clpt.1992.70","article-title":"Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2005.03.007_bib14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/clpt.1992.71","article-title":"Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2005.03.007_bib15","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/clpt.1992.72","article-title":"Long-term weight control study. IV (weeks 156 to 190). The second double-blind phase","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharacol Ther"},{"key":"10.1016\/j.ahj.2005.03.007_bib16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/clpt.1992.73","article-title":"Long-term weight control study. V (weeks 190 to 210). Follow-up of participants after cessation of medication","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2005.03.007_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/clpt.1992.74","article-title":"Long-term weight control study. VI. Individual participant response patterns","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2005.03.007_bib18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/clpt.1992.76","article-title":"Long-term weight control study: conclusions","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2005.03.007_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/jama.1994.03520030047027","article-title":"Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991","volume":"272","author":"Kuczmarski","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.03.007_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.ijo.0800541","article-title":"Overweight and obesity in the United States: prevalence and trends, 1960-1994","volume":"22","author":"Flegal","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.007_bib21","series-title":"Obesity: preventing and managing the global epidemic. Report of a WHO Consultation","year":"1998"},{"key":"10.1016\/j.ahj.2005.03.007_bib22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.7326\/0003-4819-134-4-200102200-00011","article-title":"Use of prescription weight loss pills among U.S. adults in 1996-1998","volume":"134","author":"Khan","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199509143331101","article-title":"Body weight and mortality among women","volume":"333","author":"Manson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib24","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.1993.03510230061036","article-title":"Body weight and mortality. A 27-year follow-up of middle-aged men","volume":"270","author":"Lee","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.03.007_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199801013380101","article-title":"The effect of age on the association between body-mass index and mortality","volume":"338","author":"Stevens","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ajcn\/60.2.153","article-title":"Report on the NIH workshop on pharmacologic treatment of obesity","volume":"60","author":"Atkinson","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ahj.2005.03.007_bib27","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1001\/jama.1996.03540230057036","article-title":"Long-term pharmacotherapy in the management of obesity","volume":"276","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.03.007_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/gast.2001.22430","article-title":"Current status of medical and surgical therapy for obesity","volume":"120","author":"Mun","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ahj.2005.03.007_bib29","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1210\/edrv.20.6.0383","article-title":"Current and potential drugs for treatment of obesity","volume":"20","author":"Bray","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ahj.2005.03.007_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1345\/aph.17039","article-title":"Update on the pharmacotherapy of obesity","volume":"32","author":"Cerulli","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ahj.2005.03.007_bib31","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0899-9007(00)00424-X","article-title":"A concise review on the therapeutics of obesity","volume":"16","author":"Bray","year":"2000","journal-title":"Nutrition"},{"key":"10.1016\/j.ahj.2005.03.007_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2165\/00002018-199920020-00003","article-title":"A risk-benefit assessment of anti-obesity drugs","volume":"20","author":"Kolanowski","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.ahj.2005.03.007_bib33","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","article-title":"Phenylpropanolamine and the risk of hemorrhagic stroke","volume":"343","author":"Kernan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib34","series-title":"Physicians' desk reference","year":"2000"},{"key":"10.1016\/j.ahj.2005.03.007_bib35","series-title":"Drug information handbook","year":"1998"},{"key":"10.1016\/j.ahj.2005.03.007_bib36","first-page":"55","volume":"41","year":"1999","journal-title":"Med Lett Drugs Ther"},{"key":"10.1016\/j.ahj.2005.03.007_bib37","doi-asserted-by":"crossref","first-page":"549S","DOI":"10.1002\/j.1550-8528.1995.tb00226.x","article-title":"Clinical studies with mazindol","volume":"3","author":"Inoue","year":"1995","journal-title":"Obes Res"},{"key":"10.1016\/j.ahj.2005.03.007_bib38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2125.1988.tb05303.x","article-title":"Clinical pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant, in healthy volunteers","volume":"26","author":"King","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2005.03.007_bib39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib40","series-title":"Harrison's principles of internal medicine","first-page":"438","article-title":"Physiology and pharmacology of the autonomic nervous system","author":"Lansberg","year":"2001"},{"key":"10.1016\/j.ahj.2005.03.007_bib41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0006-8993(92)91001-U","article-title":"Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists","volume":"587","author":"Tsujii","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.ahj.2005.03.007_bib42","doi-asserted-by":"crossref","first-page":"425S","DOI":"10.1002\/j.1550-8528.1995.tb00209.x","article-title":"Evaluation of drugs for treating obesity","volume":"3","author":"Bray","year":"1995","journal-title":"Obes Res"},{"key":"10.1016\/j.ahj.2005.03.007_bib43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0022-3565(24)37090-9","article-title":"In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor","volume":"283","author":"Gundlah","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ahj.2005.03.007_bib44","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2165\/00003495-199856060-00019","article-title":"Sibutramine. A review of its contribution to the management of obesity","volume":"56","author":"McNeely","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.ahj.2005.03.007_bib45","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1345\/aph.18319","article-title":"Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity","volume":"33","author":"Luque","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ahj.2005.03.007_bib46","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0278-5846(88)90003-6","article-title":"The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation","volume":"12","author":"Buckett","year":"1988","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.ahj.2005.03.007_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0029-1212035","article-title":"Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment","volume":"106","author":"Van Gaal","year":"1998","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ahj.2005.03.007_bib48","doi-asserted-by":"crossref","first-page":"553S","DOI":"10.1002\/j.1550-8528.1995.tb00227.x","article-title":"Sibutramine: a novel new agent for obesity treatment","volume":"3","author":"Ryan","year":"1995","journal-title":"Obes Res"},{"key":"10.1016\/j.ahj.2005.03.007_bib49","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.bjp.0702446","article-title":"Thermogenic effects of sibutramine and its metabolites","volume":"126","author":"Connoley","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ahj.2005.03.007_bib50","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.ijo.0801059","article-title":"The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction","volume":"23","author":"Hansen","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.007_bib51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/j.1550-8528.1996.tb00544.x","article-title":"A double-blind randomized placebo-controlled trial of sibutramine","volume":"4","author":"Bray","year":"1996","journal-title":"Obes Res"},{"key":"10.1016\/j.ahj.2005.03.007_bib52","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/clpt.1991.144","article-title":"Sibutramine in weight control: a dose-ranging, efficacy study","volume":"50","author":"Weintraub","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2005.03.007_bib53","first-page":"41","article-title":"Long-term weight loss with sibutramine [abstract]","volume":"19","author":"Jones","year":"1995","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.007_bib54","first-page":"S30","article-title":"Sibutramine\u2014a review of clinical efficacy","volume":"21","author":"Lean","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.007_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9343(98)00411-2","article-title":"Long-term maintenance of weight loss after a very\u2013low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine","volume":"106","author":"Apfelbaum","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib56","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","article-title":"Effect of sibutramine on weight maintenance after weight loss: a randomized trial. STORM Study Group. Sibutramine trial of obesity reduction and maintenance","volume":"356","author":"James","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.03.007_bib57","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1176\/ajp.148.6.705","article-title":"The serotonin syndrome","volume":"148","author":"Sternbach","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ahj.2005.03.007_bib58","first-page":"R802","article-title":"Activation of hypothalamic serotonin receptors reduced intake of dietary fat and protein but not carbohydrate","volume":"277","author":"Smith","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ahj.2005.03.007_bib59","doi-asserted-by":"crossref","first-page":"449S","DOI":"10.1002\/j.1550-8528.1995.tb00212.x","article-title":"Multiple serotonin receptors: opportunities for new treatments for obesity?","volume":"3","author":"Dourish","year":"1995","journal-title":"Obes Res"},{"key":"10.1016\/j.ahj.2005.03.007_bib60","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib61","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/01.CIR.101.17.2071","article-title":"Fenfluramine and phentermine and cardiovascular findings: effect of treatment duration on prevalence of valve abnormalities","volume":"101","author":"Jollis","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.03.007_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0195-6663(86)80050-2","article-title":"Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system","volume":"7","author":"Garattini","year":"1986","journal-title":"Appetite"},{"key":"10.1016\/j.ahj.2005.03.007_bib63","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1152\/jappl.2001.91.2.755","article-title":"Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels","volume":"91","author":"Belohlavkova","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.ahj.2005.03.007_bib64","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000441-200104000-00008","article-title":"Appetite suppressants and valvular heart disease","volume":"321","author":"Weissman","year":"2001","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ahj.2005.03.007_bib65","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(89)91499-2","article-title":"International trial of long-term dexfenfluramine in obesity","volume":"2","author":"Guy-Grand","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.03.007_bib66","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1358\/mf.2000.22.5.796647","article-title":"Efficacy of fenfluramine and dexfenfluramine in the treatment of obesity: a meta-analysis","volume":"22","author":"Carvajal","year":"2000","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.ahj.2005.03.007_bib67","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/ajcn\/61.5.1020","article-title":"Fluoxetine increases resting energy expenditure and basal body temperature in humans","volume":"61","author":"Bross","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ahj.2005.03.007_bib68","series-title":"Wellbutrin","year":"2000"},{"key":"10.1016\/j.ahj.2005.03.007_bib69","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0149-2918(00)88317-4","article-title":"A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline","volume":"21","author":"Croft","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.ahj.2005.03.007_bib70","first-page":"183","article-title":"Effects of bupropion on body weight","volume":"44","author":"Harto-Truax","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ahj.2005.03.007_bib71","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00004714-199406000-00004","article-title":"Comparison of bupropion and trazodone for the treatment of major depression","volume":"14","author":"Weisler","year":"1994","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.ahj.2005.03.007_bib72","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/oby.2001.71","article-title":"Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women","volume":"9","author":"Gadde","year":"2001","journal-title":"Obes Res"},{"key":"10.1016\/j.ahj.2005.03.007_bib73","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0149-2918(00)88301-0","article-title":"Safety profile of sustained-release bupropion in depression: results of three clinical trials","volume":"21","author":"Settle","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.ahj.2005.03.007_bib74","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.ijo.0800795","article-title":"Pharmacological treatment of obesity: present status","volume":"23","author":"Scheen","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.007_bib75","first-page":"S2","article-title":"The role of dietary fat in obesity","volume":"21","author":"Golay","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.007_bib76","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/ajcn\/68.6.1157","article-title":"Dietary fat intake does affect obesity!","volume":"68","author":"Bray","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ahj.2005.03.007_bib77","doi-asserted-by":"crossref","first-page":"309S","DOI":"10.1093\/ajcn\/55.1.309s","article-title":"Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipostatin)","volume":"55","author":"Hauptman","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ahj.2005.03.007_bib78","first-page":"241","article-title":"Lipase inhibition: a novel concept in the treatment of obesity","volume":"17","author":"Drent","year":"1993","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.007_bib79","first-page":"S12","article-title":"Mode of action of orlistat","volume":"21","author":"Guerciolini","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.007_bib80","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2165\/00003495-199958040-00015","article-title":"Orlistat: a review of its use in the management of obesity","volume":"58","author":"Hvizdos","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.ahj.2005.03.007_bib81","first-page":"221","article-title":"Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study","volume":"19","author":"Drent","year":"1995","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.007_bib82","first-page":"S24","article-title":"A one-year trial to assess the value of orlistat in the management of obesity","volume":"21","author":"James","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.007_bib83","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group","volume":"352","author":"Sjostrom","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.03.007_bib84","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s002280050433","article-title":"Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study. Orlistat Dose-Ranging Study Group","volume":"54","author":"Van Gaal","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2005.03.007_bib85","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/oby.2000.8","article-title":"Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years of treatment with orlistat for obesity. European Orlistat Obesity Study Group","volume":"8","author":"Rossner","year":"2000","journal-title":"Obes Res"},{"key":"10.1016\/j.ahj.2005.03.007_bib86","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1345\/aph.19412","article-title":"Orlistat\u2014a novel weight loss therapy","volume":"35","author":"Lucas","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ahj.2005.03.007_bib87","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/j.1552-4604.1996.tb04230.x","article-title":"The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers","volume":"36","author":"Melia","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2005.03.007_bib88","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/j.1552-4604.1996.tb04180.x","article-title":"The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of beta-carotene in healthy volunteers","volume":"36","author":"Zhi","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2005.03.007_bib89","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.281.3.235","article-title":"Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial","volume":"281","author":"Davidson","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.03.007_bib90","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF00191901","article-title":"The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia","volume":"46","author":"Tonstad","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2005.03.007_bib91","first-page":"S175","article-title":"Effect of treatment with orlistat for one year on blood pressure in obese patients [abstract]","volume":"23","author":"Pataky","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.007_bib92","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2337\/diacare.21.8.1288","article-title":"Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study","volume":"21","author":"Hollander","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2005.03.007_bib93","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0002-8223(98)00126-6","article-title":"Olestra: a new food additive","volume":"98","author":"Prince","year":"1998","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.ahj.2005.03.007_bib94","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1046\/j.1365-2036.1998.00415.x","article-title":"Review article: olestra and its gastrointestinal safety","volume":"12","author":"Thomson","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ahj.2005.03.007_bib95","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3109\/03602539709037594","article-title":"Olestra, a nonabsorbed, noncaloric replacement for dietary fat: a review","volume":"29","author":"Lawson","year":"1997","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.ahj.2005.03.007_bib96","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1001\/archinte.160.17.2600","article-title":"Changes in diet, weight, and serum lipid levels associated with olestra consumption","volume":"160","author":"Patterson","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib97","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/jn\/130.7.1711","article-title":"Olestra consumption does not predict serum concentrations of carotenoids or fat-soluble vitamins in free-living humans: early results from the sentinel site of the Olestra Post-Marketing Surveillance Study","volume":"130","author":"Thornquist","year":"2000","journal-title":"J Nutr"},{"key":"10.1016\/j.ahj.2005.03.007_bib98","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2337\/diacare.22.8.1266","article-title":"Weight change and duration of overweight and obesity in the incidence of type 2 diabetes","volume":"22","author":"Wannamethee","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2005.03.007_bib99","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2337\/diab.41.2.235","article-title":"Duration of obesity increases the incidence of NIDDM","volume":"41","author":"Everhart","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.ahj.2005.03.007_bib100","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/diacare.13.6.696","article-title":"Cellular mechanism of action of metformin","volume":"13","author":"Klip","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2005.03.007_bib101","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM199508313330903","article-title":"Metabolic effects of metformin in non\u2013insulin-dependent diabetes mellitus","volume":"333","author":"Stumvoll","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib102","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(68)92726-8","article-title":"Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics","volume":"1","author":"Clark","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.03.007_bib103","first-page":"224","article-title":"Oral antidiabetic combination therapy with sulphonylureas and metformin","volume":"17","author":"Haupt","year":"1991","journal-title":"Diabete Metab"},{"key":"10.1016\/j.ahj.2005.03.007_bib104","first-page":"201","article-title":"Comparative efficacy of metformin and glibenclamide in patients with non\u2013insulin-dependent diabetes mellitus","volume":"17","author":"Hermann","year":"1991","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ahj.2005.03.007_bib105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.2.5648.13","article-title":"Weight-reducing effect of diguanides in obese non-diabetic women","volume":"2","author":"Munro","year":"1969","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2005.03.007_bib106","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF01219646","article-title":"Effect of oral hypoglycaemic drugs on glucose tolerance and insulin secretion in borderline diabetic patients","volume":"15","author":"Papoz","year":"1978","journal-title":"Diabetologia"},{"key":"10.1016\/j.ahj.2005.03.007_bib107","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/j.1550-8528.1998.tb00314.x","article-title":"Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non\u2013insulin-dependent diabetes","volume":"6","author":"Lee","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.ahj.2005.03.007_bib108","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2362.1998.00304.x","article-title":"Effect of metformin on food intake in obese subjects","volume":"28","author":"Paolisso","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ahj.2005.03.007_bib109","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.03.007_bib110","doi-asserted-by":"crossref","first-page":"246S","DOI":"10.1093\/ajcn\/55.1.246s","article-title":"Pharmacology of thermogenic drugs","volume":"55","author":"Astrup","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ahj.2005.03.007_bib111","doi-asserted-by":"crossref","first-page":"249S","DOI":"10.1093\/ajcn\/55.1.249s","article-title":"Thermogenic effects of various beta-adrenoceptor agonists in humans: their potential usefulness in the treatment of obesity","volume":"55","author":"Jequier","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ahj.2005.03.007_bib112","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0742-8413(86)90045-9","article-title":"Caffeine and ephedrine stimulated thermogenesis in LA-corpulent rats","volume":"85","author":"Tulp","year":"1986","journal-title":"Comp Biochem Physiol C"},{"key":"10.1016\/j.ahj.2005.03.007_bib113","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1385\/ENDO:13:2:207","article-title":"Thermogenic drugs as a strategy for the treatment of obesity","volume":"13","author":"Astrup","year":"2000","journal-title":"Endocrine"},{"key":"10.1016\/j.ahj.2005.03.007_bib114","first-page":"678","article-title":"Contribution of beta 3\u2013adrenoceptor activation to ephedrine-induced thermogenesis in humans","volume":"19","author":"Liu","year":"1995","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.007_bib115","first-page":"467","article-title":"The thermogenic properties of ephedrine\/methylxanthine mixtures: human studies","volume":"10","author":"Dulloo","year":"1986","journal-title":"Int J Obes"},{"key":"10.1016\/j.ahj.2005.03.007_bib116","first-page":"269","article-title":"The effect and safety of an ephedrine\/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy-restricted diet. A double-blind trial","volume":"16","author":"Astrup","year":"1992","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.007_bib117","first-page":"51","article-title":"Coronary artery spasm and myocardial infarction in a patient with normal coronary arteries: temporal relationship to pseudoephedrine ingestion","volume":"20","author":"Wiener","year":"1990","journal-title":"Cathet Cardiovasc Diagn"},{"key":"10.1016\/j.ahj.2005.03.007_bib118","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5694\/j.1326-5377.1980.tb131811.x","article-title":"Ephedrine-induced cardiomyopathy","volume":"2","author":"To","year":"1980","journal-title":"Med J Aust"},{"key":"10.1016\/j.ahj.2005.03.007_bib119","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJM200012213432502","article-title":"Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids","volume":"343","author":"Haller","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/sj.ijo.0801539","article-title":"An herbal supplement containing Ma Huang\u2013guarana for weight loss: a randomized, double-blind trial","volume":"25","author":"Boozer","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.007_bib121","doi-asserted-by":"crossref","first-page":"604","DOI":"10.5694\/j.1326-5377.1999.tb123817.x","article-title":"The effectiveness of popular, non-prescription weight loss supplements","volume":"171","author":"Egger","year":"1999","journal-title":"Med J Aust"},{"key":"10.1016\/j.ahj.2005.03.007_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200060010-00001","article-title":"Promising new approaches to the management of obesity","volume":"60","author":"Mertens","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ahj.2005.03.007_bib123","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2125.2001.01294.x","article-title":"Drug treatment of obesity: from past failures to future successes?","volume":"51","author":"Collins","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2005.03.007_bib124","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone\u2013releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2005.03.007_bib125","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1210\/endo.141.11.7757","article-title":"Ghrelin, a novel growth hormone\u2013releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans","volume":"141","author":"Date","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ahj.2005.03.007_bib126","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2005.03.007_bib127","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","article-title":"A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans","volume":"50","author":"Cummings","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ahj.2005.03.007_bib128","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jcem.86.10.7885","article-title":"Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans","volume":"86","author":"Ariyasu","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ahj.2005.03.007_bib129","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","article-title":"Circulating ghrelin levels are decreased in human obesity","volume":"50","author":"Tschop","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ahj.2005.03.007_bib130","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa012908","article-title":"Ghrelin levels after diet-induced weight loss or gastric bypass surgery","volume":"346","author":"Cummings","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib131","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.2337\/diabetes.52.10.2546","article-title":"Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes","volume":"52","author":"Poykko","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ahj.2005.03.007_bib132","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1210\/jc.2003-030513","article-title":"Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans","volume":"88","author":"Purnell","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ahj.2005.03.007_bib133","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1210\/jc.2003-030564","article-title":"Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity","volume":"88","author":"Tassone","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ahj.2005.03.007_bib134","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","article-title":"Ghrelin enhances appetite and increases food intake in humans","volume":"86","author":"Wren","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ahj.2005.03.007_bib135","unstructured":"American College of Cardiology Scientific Sessions 2004, New Orleans, LA."},{"key":"10.1016\/j.ahj.2005.03.007_bib136","doi-asserted-by":"crossref","first-page":"516S","DOI":"10.1093\/ajcn\/55.2.516s","article-title":"Mortality of severely obese subjects","volume":"55","author":"Sjostrom","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ahj.2005.03.007_bib137","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0002-9610(92)90005-C","article-title":"Impact of gastric restrictive surgery on hypertension in the morbidly obese","volume":"163","author":"Foley","year":"1992","journal-title":"Am J Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib138","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archinte.1994.00420020107012","article-title":"The effect of gastric bypass surgery on hypertension in morbidly obese patients","volume":"154","author":"Carson","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib139","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/ajcn\/40.6.1273","article-title":"Effects of weight reduction after gastroplasty on glucose and lipid metabolism","volume":"40","author":"Olsson","year":"1984","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ahj.2005.03.007_bib140","first-page":"209","article-title":"Gastric bariatric operation in insulin-treated adults","volume":"95","author":"Herbst","year":"1984","journal-title":"Surgery"},{"key":"10.1016\/j.ahj.2005.03.007_bib141","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00000658-199509000-00011","article-title":"Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus","volume":"222","author":"Pories","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib142","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00000658-198805000-00015","article-title":"Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss","volume":"207","author":"Sugerman","year":"1988","journal-title":"Ann Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib143","doi-asserted-by":"crossref","first-page":"597S","DOI":"10.1093\/ajcn\/55.2.597s","article-title":"Long-term effects of gastric surgery for treating respiratory insufficiency of obesity","volume":"55","author":"Sugerman","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ahj.2005.03.007_bib144","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0025-6196(12)60274-2","article-title":"Severe reflux esophagitis after vertical banded gastroplasty for treatment of morbid obesity","volume":"67","author":"Kim","year":"1992","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ahj.2005.03.007_bib145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0002-9610(97)89565-7","article-title":"Conversion of failed or complicated vertical banded gastroplasty to gastric bypass in morbid obesity","volume":"171","author":"Sugerman","year":"1996","journal-title":"Am J Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib146","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archsurg.1987.01400200096018","article-title":"Reversal of benign intracranial hypertension by surgically induced weight loss","volume":"122","author":"Amaral","year":"1987","journal-title":"Arch Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib147","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0011-3840(98)80009-9","article-title":"The surgical treatment of morbid obesity","volume":"35","author":"Kellum","year":"1998","journal-title":"Curr Probl Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib148","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.HYP.36.1.20","article-title":"Differentiated long-term effects of intentional weight loss on diabetes and hypertension","volume":"36","author":"Sjostrom","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2005.03.007_bib149","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-115-12-956","article-title":"Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel","volume":"115","author":"National Institutes of Health Conference","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0002-9610(69)90113-5","article-title":"Surgical treatment of obesity","volume":"118","author":"Payne","year":"1969","journal-title":"Am J Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib151","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0002-9343(78)90233-4","article-title":"Jejunoileal bypass for morbid obesity. A critical appraisal","volume":"64","author":"Halverson","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib152","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0002-9610(80)90397-9","article-title":"Morphologic liver changes in intestinal bypass patients","volume":"139","author":"Kroyer","year":"1980","journal-title":"Am J Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib153","series-title":"Maingot's abdominal operations","first-page":"1057","article-title":"Gastric surgery for morbid obesity","author":"Sugerman","year":"1997"},{"key":"10.1016\/j.ahj.2005.03.007_bib154","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0039-6060(96)80111-5","article-title":"Biliopancreatic diversion for obesity at eighteen years","volume":"119","author":"Scopinaro","year":"1996","journal-title":"Surgery"},{"key":"10.1016\/j.ahj.2005.03.007_bib155","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1091-255X(99)80082-1","article-title":"Malabsorptive procedures for severe obesity: comparison of pancreaticobiliary bypass and very very long limb Roux-en-Y gastric bypass","volume":"3","author":"Murr","year":"1999","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib156","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1381\/096089295765557511","article-title":"Biliopancreatic diversion with a new type of gastrectomy: some previous conclusions revisited","volume":"5","author":"Lagace","year":"1995","journal-title":"Obes Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib157","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1381\/096089295765557683","article-title":"Biliopancreatic diversion, with distal gastrectomy 250 cm and 50 cm limbs: long-term results","volume":"5","author":"Marceau","year":"1995","journal-title":"Obes Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib158","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s002689900498","article-title":"Biliopancreatic diversion with duodenal switch","volume":"22","author":"Marceau","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib159","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0039-6109(16)41989-4","article-title":"Gastroplasty in morbid obesity","volume":"59","author":"Gomez","year":"1979","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.ahj.2005.03.007_bib160","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00000658-197909000-00015","article-title":"Gastric partitioning for morbid obesity","volume":"190","author":"Pace","year":"1979","journal-title":"Ann Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib161","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archsurg.1982.01380290147026","article-title":"Vertical banded gastroplasty for obesity","volume":"117","author":"Mason","year":"1982","journal-title":"Arch Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib162","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0002-9610(05)80420-9","article-title":"Results of the surgical treatment of obesity","volume":"165","author":"MacLean","year":"1993","journal-title":"Am J Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib163","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0025-6196(12)61194-X","article-title":"Prospective evaluation of vertical banded gastroplasty as the primary operation for morbid obesity","volume":"66","author":"Nightengale","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ahj.2005.03.007_bib164","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1381\/096089295765558169","article-title":"Gastric bypass and vertical banded gastroplasty\u2014a prospective randomized comparison and 5-year follow-up","volume":"5","author":"Howard","year":"1995","journal-title":"Obes Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib165","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00000658-198706000-00002","article-title":"A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters","volume":"205","author":"Sugerman","year":"1987","journal-title":"Ann Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib166","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1381\/096089200321668659","article-title":"Experience with the Roux-en-Y gastric bypass, and commentary on current trends","volume":"10","author":"Jones","year":"2000","journal-title":"Obes Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib167","first-page":"493","article-title":"Gastric banding, a surgical method of treating morbid obesity: preliminary report","volume":"7","author":"Bo","year":"1983","journal-title":"Int J Obes"},{"key":"10.1016\/j.ahj.2005.03.007_bib168","first-page":"298","article-title":"Stoma adjustable silicone gastric banding","volume":"9","author":"Kuzmak","year":"1992","journal-title":"Probl Gen Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib169","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1381\/096089295765558196","article-title":"Laparoscopic placement of adjustable silicone gastric band in the treatment of morbid obesity: how to do it","volume":"5","author":"Belachew","year":"1995","journal-title":"Obes Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1365-2168.1999.00964.x","article-title":"Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesity","volume":"86","author":"O'Brien","year":"1999","journal-title":"Br J Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib171","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s002689900499","article-title":"Laparoscopic adjustable gastric banding","volume":"22","author":"Belachew","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib172","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1381\/096089200321668730","article-title":"Adjustable gastric banding: 5-year experience","volume":"10","author":"Doldi","year":"2000","journal-title":"Obes Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib173","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1381\/096089297765555601","article-title":"The Swedish Adjustable Gastric Banding (SAGB) for morbid obesity: 9-year experience and a 4-year follow-up of patients operated with a new adjustable band","volume":"7","author":"Forsell","year":"1997","journal-title":"Obes Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib174","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1381\/096089298765554386","article-title":"Silicone-adjustable gastric banding: disappointing results","volume":"8","author":"Westling","year":"1998","journal-title":"Obes Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib175","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00000658-196909010-00003","article-title":"Gastric bypass","volume":"170","author":"Mason","year":"1969","journal-title":"Ann Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib176","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1620\/tjem.97.269","article-title":"Experimental studies on gastric bypass versus standard ulcer operations","volume":"97","author":"Ito","year":"1969","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.ahj.2005.03.007_bib177","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00000658-197710000-00012","article-title":"A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity","volume":"186","author":"Griffen","year":"1977","journal-title":"Ann Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib178","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archsurg.1977.01370070011001","article-title":"Gastric and jejunoileal bypass. A comparison in the treatment of morbid obesity","volume":"112","author":"Alden","year":"1977","journal-title":"Arch Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib179","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00000658-199204000-00014","article-title":"Long-limb gastric bypass in the superobese. A prospective randomized study","volume":"215","author":"Brolin","year":"1992","journal-title":"Ann Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib180","first-page":"37","article-title":"Pancreatic polypeptide, pancreatic glucagons and enteroglucagon in morbid obesity and following gastric bypass operation","volume":"10","author":"Meryn","year":"1986","journal-title":"Int J Obes"},{"key":"10.1016\/j.ahj.2005.03.007_bib181","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00000658-199006000-00016","article-title":"Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty","volume":"211","author":"Kellum","year":"1990","journal-title":"Ann Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib182","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0002-9610(89)90427-3","article-title":"Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment","volume":"157","author":"Sugerman","year":"1989","journal-title":"Am J Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib183","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1381\/096089294765558331","article-title":"Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases","volume":"4","author":"Wittgrove","year":"1994","journal-title":"Obes Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib184","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s004649900928","article-title":"Hand-assisted laparoscopic digestive surgery provides safety and tactile sensation for malignancy or obesity","volume":"13","author":"Naitoh","year":"1999","journal-title":"Surg Endosc"},{"key":"10.1016\/j.ahj.2005.03.007_bib185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/lap.1999.9.101","article-title":"Laparoscopic Roux-en-Y gastric bypass: a case report at one-year follow-up","volume":"9","author":"Schauer","year":"1999","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"10.1016\/j.ahj.2005.03.007_bib186","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1381\/096089299765552800","article-title":"Laparoscopic Roux-en-Y gastric bypass: a totally intra-abdominal approach\u2014technique and preliminary report","volume":"9","author":"de la Torre","year":"1999","journal-title":"Obes Surg"},{"key":"10.1016\/j.ahj.2005.03.007_bib187","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1381\/096089200321643511","article-title":"Laparoscopic gastric bypass, Roux-en-Y\u2014500 patients: technique and results, with 3-60 month follow-up","volume":"10","author":"Wittgrove","year":"2000","journal-title":"Obes Surg"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287030500253X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287030500253X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:27:02Z","timestamp":1757568422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287030500253X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":187,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S000287030500253X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2005.03.007","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological and surgical treatments for obesity","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2005.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}